ASX - By Stock
|
CHM |
Re:
CHM's Future
|
|
smashintins
|
22 |
9.4K |
5 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
22
|
9.4K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Questions for webinar
|
|
smashintins
|
14 |
4.4K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
14
|
4.4K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Questions for webinar
|
|
smashintins
|
14 |
4.4K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
14
|
4.4K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Dr Daniel Tillett appointed CEO of Race Oncology
|
|
smashintins
|
120 |
34K |
13 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
120
|
34K
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
smashintins
|
11K |
3.8M |
3 |
21/11/23 |
21/11/23 |
General
|
11K
|
3.8M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
smashintins
|
11K |
3.8M |
2 |
21/11/23 |
21/11/23 |
General
|
11K
|
3.8M
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
smashintins
|
11K |
3.8M |
2 |
21/11/23 |
21/11/23 |
General
|
11K
|
3.8M
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
smashintins
|
75 |
26K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
75
|
26K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
smashintins
|
75 |
26K |
1 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
75
|
26K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
smashintins
|
75 |
26K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
75
|
26K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
smashintins
|
745 |
298K |
5 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
745
|
298K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: ESG Report
|
|
smashintins
|
5 |
1.8K |
1 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
5
|
1.8K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Agreement with MD Anderson for Phase 1B CHM 0201 AML study
|
|
smashintins
|
23 |
9.1K |
4 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
23
|
9.1K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Agreement with MD Anderson for Phase 1B CHM 0201 AML study
|
|
smashintins
|
23 |
9.1K |
6 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
23
|
9.1K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
smashintins
|
450 |
149K |
31 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
149K
|
31
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
smashintins
|
450 |
149K |
58 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
450
|
149K
|
58
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric to receive A$4.4 million introduction fee
|
|
smashintins
|
25 |
10K |
7 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
25
|
10K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
smashintins
|
592 |
189K |
11 |
15/08/23 |
15/08/23 |
ASX - By Stock
|
592
|
189K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
smashintins
|
451 |
159K |
4 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
451
|
159K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Clinical Trials
|
|
smashintins
|
16 |
7.6K |
4 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
16
|
7.6K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Clinical Trials
|
|
smashintins
|
16 |
7.6K |
3 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
16
|
7.6K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Clinical Trials
|
|
smashintins
|
16 |
7.6K |
3 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
16
|
7.6K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
smashintins
|
11K |
3.8M |
14 |
25/06/23 |
25/06/23 |
General
|
11K
|
3.8M
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Why the land mines?
|
|
smashintins
|
8 |
2.5K |
15 |
25/06/23 |
25/06/23 |
ASX - By Stock
|
8
|
2.5K
|
15
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Share purchase plan (SPP) - closing date extended
|
|
smashintins
|
20 |
7.5K |
0 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
20
|
7.5K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
CHM-The only ASX listed CAR-T comp with 2/3 human trials
|
|
smashintins
|
13 |
6.5K |
5 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
13
|
6.5K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
smashintins
|
745 |
298K |
0 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
745
|
298K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
smashintins
|
745 |
298K |
3 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
745
|
298K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Share purchase plan (SPP) - closing date extended
|
|
smashintins
|
20 |
7.5K |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
20
|
7.5K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
smashintins
|
21K |
7.4M |
20 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
21K
|
7.4M
|
20
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Share purchase plan (SPP) - closing date extended
|
|
smashintins
|
20 |
7.5K |
5 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
20
|
7.5K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
12 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
138
|
45K
|
12
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
0 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
138
|
45K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
4 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
138
|
45K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: SPP offer documents issued to shareholders
|
|
smashintins
|
14 |
6.1K |
3 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
14
|
6.1K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
138
|
45K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
smashintins
|
21K |
7.4M |
3 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
21K
|
7.4M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race appoints Dr Michelle Rashford Chief Medical Officer
|
|
smashintins
|
32 |
12K |
7 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
32
|
12K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
6 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
138
|
45K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
2 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
138
|
45K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
0 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
138
|
45K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
0 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
138
|
45K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
2 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
138
|
45K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
6 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
138
|
45K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
How's the Capital Raise Going to Work?
|
|
smashintins
|
138 |
45K |
4 |
02/05/23 |
02/05/23 |
ASX - By Stock
|
138
|
45K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
smashintins
|
13 |
4.2K |
1 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
13
|
4.2K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
smashintins
|
13 |
4.2K |
4 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
13
|
4.2K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
smashintins
|
13 |
4.2K |
3 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
13
|
4.2K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
smashintins
|
13 |
4.2K |
5 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
13
|
4.2K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Charting Only
|
|
smashintins
|
451 |
159K |
1 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
451
|
159K
|
1
|
|